Symbols / /BDRX
/BDRX Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
- New U.S. group for those facing near-100% colon cancer risk, backed by Biodexa - Stock Titan Mon, 09 Mar 2026 12
- Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance Wed, 03 Sep 2025 07
- Biodexa Pharmaceuticals (NASDAQ: BDRX) Stock on December 10, 2025: Violent Rally, Phase 3 FAP Progress and What 2026 Might Hold - TechStock² Wed, 10 Dec 2025 08
- BDRX - Biodexa Pharmaceuticals plc Latest Stock News & Market Updates - Stock Titan Sun, 22 Feb 2026 17
- Why Did Biodexa Pharmaceuticals' Stock Drop After-Hours Despite Big Gain During Regular Trading? - webull.com hu, 09 Oct 2025 07
- Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Nasdaq ue, 20 May 2025 07
- Biodexa Stock Surges: What’s Next for Investors? - StocksToTrade Wed, 10 Dec 2025 08
- Biodexa Pharmaceuticals’ Soaring Stock: Time to Decide? - timothysykes.com Mon, 15 Dec 2025 08
- BDRX Forecast — Price Prediction for 2026. Should I Buy BDRX? - Intellectia AI Wed, 04 Jun 2025 09
- Biodexa Pharmaceuticals (BDRX) Trading Halted with Pending News - GuruFocus Wed, 30 Jul 2025 07
- Biotech firm Biodexa raises $10M to fund new treatment development - Stock Titan hu, 18 Dec 2025 08
- What Makes Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) a New Buy Stock - Yahoo Finance hu, 24 Apr 2025 07
- Biodexa Pharmaceuticals: Stock Rise Explained - StocksToTrade ue, 16 Dec 2025 08
- Biodexa’s Surge Amidst Clinical Trials – Is It Sustainable? - timothysykes.com ue, 16 Dec 2025 08
- Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision - TechStock² Wed, 10 Dec 2025 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 134.55K | 26.42K | 45.87K | 99.03K |
| TaxRateForCalcs | 0.04 | 0.05 | 0.10 | 0.11 |
| NormalizedEBITDA | -8.78M | -7.65M | -8.56M | -6.59M |
| TotalUnusualItems | 3.22M | 487.00K | 468.00K | 936.00K |
| TotalUnusualItemsExcludingGoodwill | 3.22M | 487.00K | 468.00K | 936.00K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -5.73M | -7.08M | -7.66M | -5.46M |
| ReconciledDepreciation | 254.00K | 283.00K | 343.00K | 403.00K |
| ReconciledCostOfRevenue | 5.44M | 4.07M | 5.11M | 4.65M |
| EBITDA | -5.56M | -7.16M | -8.09M | -5.66M |
| EBIT | -5.81M | -7.44M | -8.44M | -6.06M |
| NetInterestIncome | 2.00K | 42.00K | -24.00K | -44.00K |
| InterestExpense | 165.00K | 41.00K | 53.00K | 44.00K |
| InterestIncome | 167.00K | 83.00K | 29.00K | 0.00 |
| NormalizedIncome | -8.81M | -7.54M | -8.08M | -6.30M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -5.73M | -7.08M | -7.66M | -5.46M |
| TotalExpenses | 9.20M | 8.39M | 9.63M | 7.58M |
| TotalOperatingIncomeAsReported | -9.20M | -8.01M | -8.93M | -7.00M |
| DilutedAverageShares | 49.53K | 3.16K | 12.35K | 10.07K |
| BasicAverageShares | 49.53K | 3.16K | 12.35K | 10.07K |
| DilutedEPS | -100.00 | -2.00K | -155.00K | -140.00K |
| BasicEPS | -100.00 | -2.00K | -155.00K | -140.00K |
| DilutedNIAvailtoComStockholders | -5.73M | -7.08M | -7.66M | -5.46M |
| NetIncomeCommonStockholders | -5.73M | -7.08M | -7.66M | -5.46M |
| OtherunderPreferredStockDividend | 0.00 | 0.00 | ||
| NetIncome | -5.73M | -7.08M | -7.66M | -5.46M |
| NetIncomeIncludingNoncontrollingInterests | -5.73M | -7.08M | -7.66M | -5.46M |
| NetIncomeDiscontinuousOperations | 0.00 | |||
| NetIncomeContinuousOperations | -5.73M | -7.08M | -7.66M | -5.46M |
| TaxProvision | -250.00K | -406.00K | -832.00K | -646.00K |
| PretaxIncome | -5.98M | -7.49M | -8.49M | -6.11M |
| OtherIncomeExpense | 3.22M | 487.00K | 468.00K | 936.00K |
| SpecialIncomeCharges | 0.00 | 0.00 | ||
| ImpairmentOfCapitalAssets | 0.00 | 0.00 | ||
| GainOnSaleOfSecurity | 3.22M | 487.00K | 468.00K | 936.00K |
| NetNonOperatingInterestIncomeExpense | 2.00K | 42.00K | -24.00K | -44.00K |
| InterestExpenseNonOperating | 165.00K | 41.00K | 53.00K | 44.00K |
| InterestIncomeNonOperating | 167.00K | 83.00K | 29.00K | 0.00 |
| OperatingIncome | -9.20M | -8.01M | -8.93M | -7.00M |
| OperatingExpense | 3.76M | 4.33M | 4.52M | 2.92M |
| OtherOperatingExpenses | -31.00K | -14.00K | -22.00K | -24.00K |
| SellingGeneralAndAdministration | 3.79M | 4.34M | 4.54M | 2.95M |
| SellingAndMarketingExpense | 0.00 | |||
| GeneralAndAdministrativeExpense | 3.79M | 4.34M | 4.54M | 2.95M |
| OtherGandA | 3.79M | 4.34M | 4.54M | 2.95M |
| GrossProfit | -5.44M | -3.69M | -4.41M | -4.08M |
| CostOfRevenue | 5.44M | 4.07M | 5.11M | 4.65M |
| TotalRevenue | 0.00 | 381.00K | 699.00K | 578.00K |
| OperatingRevenue | 0.00 | 381.00K | 699.00K | 578.00K |
| Line Item | 2022-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 6.69B | 1.19B | 5.42M | 4.92M |
| ShareIssued | 6.69B | 1.19B | 5.42M | 4.92M |
| TotalDebt | 727.00K | 464.00K | 624.00K | 766.00K |
| TangibleBookValue | 2.68M | 1.74M | 3.16M | 10.45M |
| InvestedCapital | 8.32M | 4.68M | 3.16M | 10.45M |
| WorkingCapital | 3.78M | 1.46M | 2.79M | 9.92M |
| NetTangibleAssets | 2.68M | 1.74M | 3.16M | 10.45M |
| CapitalLeaseObligations | 727.00K | 464.00K | 624.00K | 766.00K |
| CommonStockEquity | 8.32M | 4.68M | 3.16M | 10.45M |
| TotalCapitalization | 8.32M | 4.68M | 3.16M | 10.45M |
| TotalEquityGrossMinorityInterest | 8.32M | 4.68M | 3.16M | 10.45M |
| StockholdersEquity | 8.32M | 4.68M | 3.16M | 10.45M |
| OtherEquityInterest | 5.93M | 8.52M | 1.72M | 1.72M |
| GainsLossesNotAffectingRetainedEarnings | 53.00M | 53.00M | 53.00M | 53.00M |
| OtherEquityAdjustments | 53.00M | 53.00M | 53.00M | 53.00M |
| ForeignCurrencyTranslationAdjustments | 0.00 | 0.00 | ||
| RetainedEarnings | -150.42M | -144.77M | -135.34M | -127.80M |
| AdditionalPaidInCapital | 93.12M | 86.73M | 83.67M | 83.43M |
| CapitalStock | 6.69M | 1.19M | 108.34K | 98.47K |
| CommonStock | 6.69M | 1.19M | 108.34K | 98.47K |
| TotalLiabilitiesNetMinorityInterest | 6.46M | 5.86M | 2.36M | 2.46M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 1.42M | 295.00K | 462.66K | 619.53K |
| OtherNonCurrentLiabilities | 1.31M | -344.00 | -469.00 | |
| LongTermDebtAndCapitalLeaseObligation | 118.00K | 295.00K | 463.00K | 620.00K |
| LongTermCapitalLeaseObligation | 118.00K | 295.00K | 463.00K | 620.00K |
| LongTermDebt | 0.00 | |||
| CurrentLiabilities | 5.03M | 5.57M | 1.90M | 1.84M |
| OtherCurrentLiabilities | 921.00K | 4.16M | 85.00K | 553.00K |
| CurrentDeferredLiabilities | 1.47M | 0.00 | 197.00K | 0.00 |
| CurrentDeferredRevenue | 1.47M | 0.00 | 197.00K | 0.00 |
| CurrentDebtAndCapitalLeaseObligation | 609.00K | 169.00K | 161.00K | 146.00K |
| CurrentCapitalLeaseObligation | 609.00K | 169.00K | 161.00K | 146.00K |
| CurrentDebt | 0.00 | 0.00 | ||
| CurrentProvisions | 207.00K | 50.00K | ||
| PayablesAndAccruedExpenses | 2.04M | 1.24M | 1.25M | 1.09M |
| CurrentAccruedExpenses | 1.27M | 857.00K | 817.00K | 546.00K |
| Payables | 763.00K | 383.00K | 433.00K | 546.00K |
| OtherPayable | 6.00K | 7.00K | 17.00K | 5.00K |
| TotalTaxPayable | 50.00K | 62.00K | 77.00K | 56.00K |
| AccountsPayable | 707.00K | 314.00K | 339.00K | 485.00K |
| TotalAssets | 14.78M | 10.54M | 5.53M | 12.91M |
| TotalNonCurrentAssets | 5.97M | 3.51M | 837.00K | 1.15M |
| GoodwillAndOtherIntangibleAssets | 5.65M | 2.94M | 6.00K | 0.00 |
| OtherIntangibleAssets | 5.65M | 2.94M | 6.00K | |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 |
| NetPPE | 324.00K | 571.00K | 831.00K | 1.15M |
| AccumulatedDepreciation | -1.22M | -1.73M | -1.63M | -1.64M |
| GrossPPE | 1.54M | 2.30M | 2.46M | 2.79M |
| Leases | 53.00K | 53.00K | 53.00K | 53.00K |
| OtherProperties | 1.40M | 2.13M | 2.26M | 2.44M |
| MachineryFurnitureEquipment | 88.00K | 113.00K | 151.00K | 302.00K |
| BuildingsAndImprovements | 53.00K | 53.00K | ||
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 8.81M | 7.03M | 4.69M | 11.76M |
| PrepaidAssets | 6.43M | 355.00K | 376.00K | 607.00K |
| Receivables | 715.00K | 704.00K | 1.48M | 1.10M |
| OtherReceivables | 131.00K | 282.00K | 301.00K | 394.00K |
| TaxesReceivable | 573.00K | 422.00K | 846.00K | 670.00K |
| AccountsReceivable | 11.00K | 0.00 | 329.00K | 33.00K |
| CashCashEquivalentsAndShortTermInvestments | 1.67M | 5.97M | 2.84M | 10.06M |
| CashAndCashEquivalents | 1.67M | 5.97M | 2.84M | 10.06M |
| CashFinancial | 1.67M | 5.97M | 2.84M | 10.06M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -13.04M | -7.09M | -7.11M | -6.33M |
| RepaymentOfDebt | -186.00K | -188.00K | -178.00K | -215.00K |
| IssuanceOfDebt | 431.00K | 0.00 | 0.00 | 0.00 |
| IssuanceOfCapitalStock | 8.31M | 10.43M | 243.00K | 9.04M |
| CapitalExpenditure | -774.00K | -263.00K | -62.00K | -320.00K |
| EndCashPosition | 1.67M | 5.97M | 2.84M | 10.06M |
| BeginningCashPosition | 5.97M | 2.84M | 10.06M | 7.55M |
| EffectOfExchangeRateChanges | 0.00 | 0.00 | 0.00 | -8.00K |
| ChangesInCash | -4.30M | 3.13M | -7.22M | 2.52M |
| FinancingCashFlow | 8.56M | 10.23M | 47.00K | 8.80M |
| CashFlowFromContinuingFinancingActivities | 8.56M | 10.23M | 47.00K | 8.80M |
| InterestPaidCFF | 0.00 | -13.00K | -18.00K | -15.00K |
| CashDividendsPaid | 0.00 | 0.00 | 0.00 | 0.00 |
| NetCommonStockIssuance | 8.31M | 10.43M | 243.00K | 9.04M |
| CommonStockIssuance | 8.31M | 10.43M | 243.00K | 9.04M |
| NetIssuancePaymentsOfDebt | 245.00K | -188.00K | -178.00K | -215.00K |
| NetShortTermDebtIssuance | 431.00K | 0.00 | 0.00 | |
| ShortTermDebtIssuance | 431.00K | 0.00 | 0.00 | |
| NetLongTermDebtIssuance | -186.00K | -188.00K | -178.00K | -215.00K |
| LongTermDebtPayments | -186.00K | -188.00K | -178.00K | -215.00K |
| LongTermDebtIssuance | 0.00 | 0.00 | ||
| InvestingCashFlow | -598.00K | -265.00K | -220.00K | -278.00K |
| CashFlowFromContinuingInvestingActivities | -598.00K | -265.00K | -220.00K | -278.00K |
| NetOtherInvestingChanges | -79.00K | -207.00K | ||
| InterestReceivedCFI | 176.00K | 73.00K | 29.00K | 0.00 |
| NetBusinessPurchaseAndSale | 0.00 | |||
| PurchaseOfBusiness | 0.00 | |||
| NetIntangiblesPurchaseAndSale | -765.00K | -237.00K | 0.00 | 0.00 |
| PurchaseOfIntangibles | -765.00K | -237.00K | 0.00 | 0.00 |
| NetPPEPurchaseAndSale | -9.00K | -22.00K | -42.00K | -278.00K |
| SaleOfPPE | 0.00 | 4.00K | 20.00K | 42.00K |
| PurchaseOfPPE | -9.00K | -26.00K | -62.00K | -320.00K |
| OperatingCashFlow | -12.26M | -6.83M | -7.05M | -6.01M |
| CashFlowFromContinuingOperatingActivities | -12.26M | -6.83M | -7.05M | -6.01M |
| TaxesRefundPaid | 129.00K | 845.00K | 678.00K | 1.16M |
| ChangeInWorkingCapital | -3.74M | -49.00K | 520.00K | -617.00K |
| ChangeInOtherWorkingCapital | -207.00K | 157.00K | ||
| ChangeInPayablesAndAccruedExpense | 2.24M | -207.00K | 356.00K | -130.00K |
| ChangeInPayable | 2.24M | -207.00K | 356.00K | -130.00K |
| ChangeInReceivables | -5.97M | 365.00K | 7.00K | -487.00K |
| OtherNonCashItems | -2.00K | -42.00K | 24.00K | 44.00K |
| StockBasedCompensation | 283.00K | 28.00K | 123.00K | 89.00K |
| AssetImpairmentCharge | 0.00 | 79.00K | 207.00K | 0.00 |
| DeferredTax | -250.00K | -406.00K | -832.00K | -646.00K |
| DeferredIncomeTax | -250.00K | -406.00K | -832.00K | -646.00K |
| DepreciationAmortizationDepletion | 254.00K | 283.00K | 343.00K | 403.00K |
| DepreciationAndAmortization | 254.00K | 283.00K | 343.00K | 403.00K |
| AmortizationCashFlow | 2.00K | 3.00K | 3.00K | 0.00 |
| AmortizationOfIntangibles | 2.00K | 3.00K | 3.00K | 0.00 |
| Depreciation | 252.00K | 280.00K | 340.00K | 403.00K |
| OperatingGainsLosses | -3.21M | -485.00K | -455.00K | -978.00K |
| GainLossOnInvestmentSecurities | -3.22M | -487.00K | -468.00K | -936.00K |
| NetForeignCurrencyExchangeGainLoss | 4.00K | 0.00 | -1.00K | -3.00K |
| GainLossOnSaleOfPPE | 4.00K | 2.00K | 14.00K | -39.00K |
| NetIncomeFromContinuingOperations | -5.73M | -7.08M | -7.66M | -5.46M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for /BDRX
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|